These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 6087862

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Bone scintigram in cardiac amyloidosis: a case report.
    Ali A, Turner DA, Rosenbush SW, Fordham EW.
    Clin Nucl Med; 1981 Mar; 6(3):105-8. PubMed ID: 6257442
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.
    Nagai T, Horinouchi H, Hashimoto K, Ichiji T, Yoshioka K, Hashimoto J, Ikari Y.
    Echocardiography; 2023 Jul; 40(7):634-641. PubMed ID: 37243310
    [Abstract] [Full Text] [Related]

  • 28. Myocardial uptake of technetium-99m pyrophosphate in systemic amyloidosis.
    Ptacin MJ.
    Am J Cardiol; 1984 Oct 01; 54(7):938-9. PubMed ID: 6091435
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease.
    Schiff S, Bateman T, Moffatt R, Davidson R, Berman D.
    Am Heart J; 1982 Apr 01; 103(4 Pt 1):562-3. PubMed ID: 6278907
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis].
    Fujii T, Tanaka M, Yazaki Y, Kitabayashi H, Koizumi T, Hongo M, Sekiguchi M, Itoh A, Gomi T, Yano K.
    Kaku Igaku; 1997 Nov 01; 34(11):1033-9. PubMed ID: 9455044
    [Abstract] [Full Text] [Related]

  • 35. Technetium 99m-pyrophosphate scintigraphy in amyloid cardiomyopathy.
    Ptacin MJ, Bamrah V, Duthie E.
    Wis Med J; 1985 Mar 01; 84(3):25-7. PubMed ID: 2986368
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.
    Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H.
    J Cardiol; 2021 Feb 01; 77(2):124-130. PubMed ID: 33132078
    [Abstract] [Full Text] [Related]

  • 40. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
    Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, Guendouz S, Tissot CM, Hittinger L, Dubois-Randé JL, Plante-Bordeneuve V, Itti E, Meignan M, Damy T.
    Amyloid; 2015 Feb 01; 22(4):210-20. PubMed ID: 26465835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.